[3]Wang ML, Barrientos JC, Furman RR, et al. Zilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid Cancers. NEJM; Published online 12 October 2021. ；[4] Borcherding N, Kusner D, Liu GH, Zhang W. ROR1, an embryonic protein with an emerging role in cancer biology. Protein...
[4]Balakrishnan A, Goodpaster T, Randolph-Habecker J, Hoffstrom BG, Jalikis FG, Koch LK, Berger C, Kosasih PL, Rajan A, Sommermeyer D, Porter PL, Riddell SR. Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues....
[4] Balakrishnan A, Goodpaster T, Randolph-Habecker J, Hoffstrom BG, Jalikis FG, Koch LK, Berger C, Kosasih PL, Rajan A, Sommermeyer D, Porter PL, Riddell SR. Analysis ofROR1Protein Expression in Human Cancer and Normal Tissues. Clin Cancer Res. 2017....
GENE expressionPANCREATIC cancerPROGNOSISOVERALL survivalDRUG targetThe Wnt receptors ROR1 and ROR2 are generating increased interest as cancer therapeutic targets but remain understudied in pancreatic ductal adenocarcinoma (PDAC). Compared to canonical Wnt/ 尾-catenin signalling, the role of noncanonical ...
[4]Balakrishnan A, Goodpaster T, Randolph-Habecker J, Hoffstrom BG, Jalikis FG, Koch LK, Berger C, Kosasih PL, Rajan A, Sommermeyer D, Porter PL, Riddell SR. Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues. Clin Cancer Res. 2017....
Analysis of ROR1 protein expression in human cancer and normal tissues[J]. Clinical Cancer Research, 2017, 23(12): 3061-3071. [5]cstonepharma.com/html/n 发布于 2025-04-24 13:17・上海 ADC药物 实体瘤 赞同1添加评论 分享喜欢收藏申请转载 ...
[4] Balakrishnan A, Goodpaster T, Randolph-Habecker J, Hoffstrom BG, Jalikis FG, Koch LK, Berger C, Kosasih PL, Rajan A, Sommermeyer D, Porter PL, Riddell SR. Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues. Clin Cancer Res. 2017. ...
[4] Boreherding N, Kusner D, Liu GH, et al. ROR1, an embryonic protein with an emerging role in cancer biology [J]. Protein Cell. 2014, 5:496-502.[5] Baskar S, K wong KY, .Hofer T, et al. Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell ...
[5] Balakrishnan A, Goodpaster T, Randolph-Habecker J, Hoffstrom BG, Jalikis FG, Koch LK, Berger C, Kosasih PL, Rajan A, Sommermeyer D, Porter PL, Riddell SR. Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues. Clin Cancer Res. 2017. ...
Results:1.ThepositiverateofROR1inbreastcancerwas73.9%(102/138).The positiverateoftriplenegativebreastcancerwas91.3%(63/69),thehighexpressionrate was57.9%(40/69),andthelowexpressionratewas33.3%(23/69).Inothersubtypesof breastcancer,thepositiveratewas56.6%(39/69),thehighexpressionratewas15.9% ...